Abstract Details
|
Kimford J. Meador, MD, FÂ鶹´«Ã½Ó³»
(Stanford University School of Medicine)
PRESENTER |
The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium. |
| Frank G. Gilliam, MD, MPH (University of Kentucky) | No disclosure on file |
| Robert E. Hogan, MD (Washington Univ in St Louis/Neuro Dept) | Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics. |
| Mary J. Holmay, RN, BSN (Greenwich Biosciences (GW Pharmaceuticals)) | No disclosure on file |
| Annie Clark | No disclosure on file |
| Bob Anders | No disclosure on file |
| Michael Strupp, MD, DO, FÂ鶹´«Ã½Ó³» (Hospital of the Ludwig Maximilians University, Munich, Dept of Neurology) | Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has or had stock in IntraBio. |